Cite Filings / PCVX / 0001897612-26-000705

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Vaxcyte, Inc. Filed 2026-11-06 Acc 0001897612-26-000705

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-11-06 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-11-06 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-11-04 4 SVP, Finance & CAO sold 3,000 shares at an average $60.92 ($182,753)
2026-11-04 4 EVP, Chief Scientific Ofc, COO sold 2,250 shares at an average $60.90 ($137,024)
2026-11-04 10-Q Quarterly Report
2026-11-04 8-K Results of operations
2026-11-02 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…